Dow Up 0.44% Nasdaq Up 0.01%

Athersys, Inc. (ATHX)

-NasdaqCM
1.47 Down 0.03(2.00%) 12:10PM EDT - Nasdaq Real Time Price
Prev Close:1.50
Open:1.51
Bid:1.47 x 2200
Ask:1.49 x 2300
1y Target Est:6.25
Beta:0.59
Next Earnings Date:N/A
Day's Range:1.46 - 1.52
52wk Range:1.08 - 4.33
Volume:115,098
Avg Vol (3m):406,377
Market Cap:113.26M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which has Phase I... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback